GENEVA, July 9 -- QILU PHARMACEUTICAL CO., LTD. filed a patent application (CN2025/147397) for “CRYSTAL FORM OF KAT6A/B INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF”. With publication no. WO/2026/145581, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 413/14

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....